Advertisement
CBUS vs ELDN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBUS is a Hold and ELDN is a StrongBuy.
Momentum Indicator for CBUS turns negative, indicating new downward trend
CBUS saw its Momentum Indicator move below the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned negative. In 77 of the 85 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for CBUS turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 40 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CBUS moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBUS entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CBUS's RSI Oscillator exited the oversold zone, 36 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 62 cases where CBUS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
Following a +7.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBUS advanced for three days, in 210 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
CBUS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. CBUS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.229) is normal, around the industry mean (2.973). P/E Ratio (-0.927) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (21.692) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBUS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ELDN sees its Stochastic Oscillator ascends from oversold territory
On October 22, 2026, the Stochastic Oscillator for ELDN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In 59 of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ELDN's RSI Indicator exited the oversold zone, 25 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Moving Average Convergence Divergence (MACD) for ELDN just turned positive on October 21, 2026. Looking at past instances where ELDN's MACD turned positive, the stock continued to rise in 40 of 46 cases over the following month. The odds of a continued upward trend are 87%.
Following a +2.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELDN advanced for three days, in 222 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
ELDN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELDN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for ELDN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.661) is normal, around the industry mean (2.973). P/E Ratio (-2.556) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. ELDN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CBUS | ELDN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 79 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | 71 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 73 | 83 | |
P/E GROWTH RATING 1..100 | 20 | 98 | |
SEASONALITY SCORE 1..100 | 38 | 27 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ELDN's Valuation (71) in the Pharmaceuticals Major industry is in the same range as CBUS (76) in the null industry. This means that ELDN’s stock grew similarly to CBUS’s over the last 12 months.
ELDN's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CBUS (100) in the null industry. This means that ELDN’s stock grew similarly to CBUS’s over the last 12 months.
ELDN's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as CBUS (100) in the null industry. This means that ELDN’s stock grew similarly to CBUS’s over the last 12 months.
CBUS's Price Growth Rating (73) in the null industry is in the same range as ELDN (83) in the Pharmaceuticals Major industry. This means that CBUS’s stock grew similarly to ELDN’s over the last 12 months.
CBUS's P/E Growth Rating (20) in the null industry is significantly better than the same rating for ELDN (98) in the Pharmaceuticals Major industry. This means that CBUS’s stock grew significantly faster than ELDN’s over the last 12 months.
| CBUS | ELDN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 89% |
| Stochastic ODDS (%) | 1 day ago 87% | 1 day ago 89% |
| Momentum ODDS (%) | 1 day ago 90% | N/A |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 87% |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 89% | 1 day ago 88% |
| Advances ODDS (%) | 2 days ago 84% | 1 day ago 88% |
| Declines ODDS (%) | 8 days ago 90% | 9 days ago 88% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CBUS’s FA Score shows that 1 FA rating(s) are green while ELDN’s FA Score has 0 green FA rating(s).
- CBUS’s FA Score: 1 green, 4 red.
- ELDN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CBUS’s TA Score shows that 4 TA indicator(s) are bullish while ELDN’s TA Score has 5 bullish TA indicator(s).
- CBUS’s TA Score: 4 bullish, 5 bearish.
- ELDN’s TA Score: 5 bullish, 3 bearish.
Price Growth
CBUS (@Biotechnology) experienced а +0.71% price change this week, while ELDN (@Biotechnology) price change was +0.44% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
CBUS is expected to report earnings on Nov 12, 2026.
ELDN is expected to report earnings on Nov 13, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
CBUS and
Correlation & Price change
A.I.dvisor tells us that CBUS and ABOS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CBUS and ABOS's prices will move in lockstep.
| Ticker / NAME | Correlation To CBUS | 1D Price Change % | ||
|---|---|---|---|---|
| CBUS | 100% | -0.71% | ||
| ABOS - CBUS | 33% Poorly correlated | +1.48% | ||
| ELDN - CBUS | 32% Poorly correlated | +1.77% | ||
| QSI - CBUS | 31% Poorly correlated | -6.50% | ||
| DNLI - CBUS | 29% Poorly correlated | -0.11% | ||
| TELO - CBUS | 29% Poorly correlated | -0.98% | ||
More | ||||
ELDN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with EDIT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To ELDN | 1D Price Change % | ||
|---|---|---|---|---|
| ELDN | 100% | +1.77% | ||
| EDIT - ELDN | 35% Loosely correlated | -0.80% | ||
| STRO - ELDN | 34% Loosely correlated | -4.63% | ||
| NTLA - ELDN | 34% Loosely correlated | -4.21% | ||
| RLAY - ELDN | 33% Poorly correlated | -0.38% | ||
| DNLI - ELDN | 32% Poorly correlated | -0.11% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DFGR | 27.67 | 0.27 | +0.99% |
| Dimensional Global Real Estate ETF (DFGR) | |||
| RYLG | 23.13 | N/A | +0.01% |
| Global X Russell 2000 Covered Call & Growth ETF (RYLG) | |||
| MKTN | 28.49 | -0.09 | -0.31% |
| Federated Hermes MDT Market Neutral ETF (MKTN) | |||
| QMNV | 25.69 | -0.16 | -0.62% |
| FT Vest Nasdaq-100 Moderate Buffer ETF - November (QMNV) | |||
| SPYU | 33.09 | -1.67 | -4.80% |
| MAX S&P 500 4X Leveraged ETN (SPYU) | |||